Intellia Therapeutics, Inc. (NTLA)
9.78
-0.08
(-0.81%)
USD |
NASDAQ |
Nov 17, 16:00
9.85
+0.07
(+0.72%)
After-Hours: 20:00
Intellia Therapeutics Price : 9.78 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 9.98 | 10.46 | 9.70 | 9.86 | 6.611M |
| Nov 13, 2026 | 10.45 | 10.50 | 9.665 | 9.70 | 11.42M |
| Nov 12, 2026 | 11.00 | 11.06 | 10.46 | 10.55 | 4.005M |
| Nov 11, 2026 | 11.30 | 11.64 | 11.12 | 11.41 | 3.035M |
| Nov 10, 2026 | 11.87 | 11.92 | 10.96 | 11.17 | 4.208M |
| Nov 09, 2026 | 11.36 | 12.14 | 11.15 | 12.11 | 4.173M |
| Nov 06, 2026 | 11.26 | 11.40 | 11.02 | 11.35 | 4.405M |
| Nov 05, 2026 | 12.26 | 12.26 | 10.86 | 11.10 | 7.615M |
| Nov 04, 2026 | 12.26 | 12.53 | 11.90 | 12.31 | 3.171M |
| Nov 03, 2026 | 11.73 | 12.38 | 11.72 | 11.86 | 2.887M |
| Nov 02, 2026 | 12.60 | 12.61 | 11.59 | 11.66 | 3.884M |
| Oct 30, 2026 | 12.88 | 13.16 | 12.04 | 12.47 | 4.088M |
| Oct 29, 2026 | 13.32 | 13.94 | 12.92 | 13.23 | 4.704M |
| Oct 28, 2026 | 12.08 | 13.34 | 11.93 | 13.32 | 4.908M |
| Oct 27, 2026 | 11.30 | 12.31 | 11.17 | 12.28 | 3.851M |
| Oct 26, 2026 | 11.24 | 11.44 | 11.09 | 11.26 | 2.065M |
| Oct 23, 2026 | 11.00 | 11.24 | 10.58 | 11.21 | 3.567M |
| Oct 22, 2026 | 11.41 | 11.96 | 10.98 | 11.16 | 3.651M |
| Oct 21, 2026 | 11.84 | 11.91 | 11.55 | 11.65 | 2.829M |
| Oct 20, 2026 | 11.46 | 12.00 | 11.28 | 11.84 | 3.417M |
| Oct 19, 2026 | 11.54 | 11.85 | 11.33 | 11.58 | 3.505M |
| Oct 16, 2026 | 11.60 | 11.68 | 10.91 | 11.42 | 8.236M |
| Oct 15, 2026 | 11.33 | 11.82 | 11.10 | 11.34 | 6.529M |
| Oct 14, 2026 | 11.83 | 11.87 | 11.28 | 11.43 | 5.439M |
| Oct 13, 2026 | 12.30 | 12.48 | 11.82 | 11.91 | 5.180M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 112.05 |
| Beam Therapeutics, Inc. | 20.66 |
| Prime Medicine, Inc. | 3.83 |
| 10X Genomics, Inc. | 56.34 |
| Moderna, Inc. | 206.69 |
Price Related Metrics
| PS Ratio | 23.49 |
| Price to Book Value | 2.237 |
| Earnings Yield | -34.22% |
| Market Cap | 1.372B |